Patents by Inventor ERIK C. DREADEN

ERIK C. DREADEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250041413
    Abstract: This disclosure relates to libraries of multi-cytokine binding particles or other surfaces and uses in method for screening immune cells for improved immune modulating functionality. In certain embodiments, the libraries are used to identify desirable particles for stimulating immune cells useful for cancer and other immune cell therapies.
    Type: Application
    Filed: December 1, 2022
    Publication date: February 6, 2025
    Inventors: Sarwish Rafiq, Erik C. Dreaden, A K M Nawshad Hossain, Biaggio Uricoli, Heather Lin
  • Publication number: 20110077581
    Abstract: The various embodiments of the present disclosure relate generally to compositions and methods for the targeted cellular delivery of nanoparticles. More particularly, the various embodiments of the present invention are directed to the cellular delivery of nanoparticles tethered to a ligand by way of a poly(ethylene glycol) linkage, wherein the ligand demonstrates a binding specificity for a cellular target. In an exemplary embodiment, the ligand is tamoxifen and the cellular target is the estrogen receptor, which is upregulated in many breast cancer cells.
    Type: Application
    Filed: September 24, 2010
    Publication date: March 31, 2011
    Applicant: GEORGIA TECH RESEARCH CORPORATION
    Inventors: ADEGBOYEGA K. OYELERE, MOSTAFA A. EL-SAYED, ERIK C. DREADEN